Cargando…
How molecular advances may improve the diagnosis and management of PTCL patients
Peripheral T-cell lymphomas (PTCL) comprised more than 30 rare heterogeneous entities, representing 10 to 15% of adult non-Hodgkin lymphomas. Although their diagnosis is still mainly based on clinical, pathological, and phenotypic features, molecular studies have allowed for a better understanding o...
Autores principales: | Drieux, Fanny, Lemonnier, François, Gaulard, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328093/ https://www.ncbi.nlm.nih.gov/pubmed/37427095 http://dx.doi.org/10.3389/fonc.2023.1202964 |
Ejemplares similares
-
Editorial: PTCL from genes to therapy
por: Janikova, Andrea
Publicado: (2022) -
PTCL, NOS: An update on classification, risk-stratification, and treatment
por: Weiss, Jonathan, et al.
Publicado: (2023) -
Burrowing through the Heterogeneity: Review of Mouse Models of PTCL-NOS
por: Cutucache, Christine E., et al.
Publicado: (2016) -
Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?
por: Couto, Samuel C. F., et al.
Publicado: (2023) -
A Novel Mechanism of Action of Histone Deacetylase Inhibitor Chidamide: Enhancing the Chemotaxis Function of Circulating PD-1(+) Cells From Patients With PTCL
por: Wei, Chong, et al.
Publicado: (2021)